The activity of cefotetan against 430 strains of anaerobic bacteria was compared with that of cefoxitin, ceftizoxime, clindamycin, metronidazole, and chloramphenicol. Percent susceptible values for the Bacteroides fragilis group were 60, 80, 29, 86, 100, and 100%, respectively. Percent susceptible values for the B. fragilis species were 91, 92, 46, 98, 100, and 100%, respectively. Non-B. fragilis-group Bacteroides species were inhibited very well (90 to 100%) by all drugs except ceftizoxime (80%). Cefotetan and metronidazole were the most active agents against Clostridium difficile. Percent susceptible values for all strains were 72, 79, 44, 82, 93, and 98%, respectively. In light of the recent emphasis on cost containment considerations in decisions regarding antimicrobial therapy, we evaluated several of the drugs currently being compared as antianaerobic agents and compared them with other antimicrobial agents considered "gold standards" for therapy of anaerobic infections. Cefotetan is a 7-a-methoxy cephalosporin of the cephamycin class with a wide range of in vitro activity (6-8, 10, 11). Cefotetan and ceftizoxime both have longer half-lives than many of the other commonly used cephalosporins, and this allows for less-frequent dosing (3, 4) . A number of cephalosporins are stable to many 1-lactamases, including those from the Bacteroides fragilis group, although this does not necessarily reflect activity against those species of organisms. In this study, the activity of cefotetan against anaerobic bacteria was compared with that of cefoxitin, ceftizoxime, clindamycin, metronidazole, and chloramphenicol. All bacteria were randomly selected recent clinical isolates from the Veterans Administration Wadsworth Medical Center, Los Angeles. Bacteria were identified by established procedures (5, 9). MICs were determined by an agar dilution technique described previously (9) with an inoculum of 105 CFU and brucella baselaked blood agar. Plates were incubated in GasPak jars (BBL Microbiology Systems, Cockeysville, Md.) for 48 h at 37°C. MICs were defined as the lowest concentration of antimicrobial agent permitting no growth, one discrete colony, or a barely visible haze. Reference strains of B. fragilis (ATCC 25285) and Bacteroides thetaiotaomicron (ATCC 29741) were used as controls in each test.
In light of the recent emphasis on cost containment considerations in decisions regarding antimicrobial therapy, we evaluated several of the drugs currently being compared as antianaerobic agents and compared them with other antimicrobial agents considered "gold standards" for therapy of anaerobic infections. Cefotetan is a 7-a-methoxy cephalosporin of the cephamycin class with a wide range of in vitro activity (6-8, 10, 11) . Cefotetan and ceftizoxime both have longer half-lives than many of the other commonly used cephalosporins, and this allows for less-frequent dosing (3, 4) . A number of cephalosporins are stable to many 1- lactamases, including those from the Bacteroides fragilis group, although this does not necessarily reflect activity against those species of organisms. In this study, the activity of cefotetan against anaerobic bacteria was compared with that of cefoxitin, ceftizoxime, clindamycin, metronidazole, and chloramphenicol. All bacteria were randomly selected recent clinical isolates from the Veterans Administration Wadsworth Medical Center, Los Angeles. Bacteria were identified by established procedures (5, 9) . MICs were determined by an agar dilution technique described previously (9) with an inoculum of 105 CFU and brucella baselaked blood agar. Plates were incubated in GasPak jars (BBL Microbiology Systems, Cockeysville, Md.) for 48 h at 37°C. MICs were defined as the lowest concentration of antimicrobial agent permitting no growth, one discrete colony, or a barely visible haze. Reference strains of B. fragilis (ATCC 25285) and Bacteroides thetaiotaomicron (ATCC 29741) were used as controls in each test.
The results of the study are summarized in Table 1 . As noted in other reports by our laboratory (12) (13) (14) and others (1, 2) , it is crucial to differentiate between the species B. fragilis and the B. fragilis group. B. fragilis tends to be much more susceptible to many antimicrobial agents than the other members of the group, and it is often difficult to compare data from different laboratories if the same species are not included. To facilitate such comparisons, we report the results for B. fragilis alone, for the B. fragilis group including B. fragilis, and for the B. fragilis group excluding B. fragilis. MICs for organisms in the B. fragilis group often cluster at or near clinically achievable levels (one method of defining a breakpoint), so percent susceptible values are reported at a selected range of concentrations above and below the breakpoint. Further, although breakpoints are determined by maximal achievable serum levels, in actual practice a lower than maximal dosage regimen is often used with some drugs, and a lower breakpoint may therefore be more relevant. For these reasons, we present the percent susceptible values over a concentration range, rather than at one breakpoint. Our estimations of breakpoints (based on Food and Drug Administration-approved package inserts when such information is available), as well as percent susceptible at the breakpoint, are underlined in Table 1 .
Metronidazole and chloramphenicol were the most active agents against the B. fragilis group of organisms, inhibiting 100% of the strains at 16 ,ug/ml. Clindamycin inhibited 75, 86, and 92% at 2, 4 (breakpoint), and 8 ,ug/ml, respectively. Cefoxitin inhibited 50, 80, and 97% of the strains, respectively, at 16, 32, and 64 pig/ml, while cefotetan inhibited 53, 60 , and 65% at these concentrations. Ceftizoxime inhibited 13, 29, and 65% at these concentrations.
Activity against the species B. fragilis was highest with metronidazole and chloramphenicol (100% inhibited at 16 ,ug/ml), very good for clindamycin (98% at 4 jxg/ml), approximately equal for cefoxitin and cefotetan at 32 ,ug/ml (91 and 92%, respectively), and poorest for ceftizoxime (46% at 32 ,ug/ml). Cefotetan was more active than cefoxitin at 16 ,ug/ml (89% versus 78%), while cefoxitin was slightly more active at 64 jig/ml (98% versus 93%).
Other Bacteroides species were inhibited best by chloramphenicol and metronidazole (100%), very well by clindamycin, cefotetan, and cefoxitin (94 to 96%), and reasonably well by ceftizoxime (80%). Fusobacterium f Actinomyces species (6 strains), Eubacterium species (7 strains), Lactobacillus species (2 strains), and Propionibacterium species (5 strains). g P. anaerobius (2 strains), P. asaccharolyticus (8 strains), P. magnus (6 strains), P. prevotii (4 strains), P. micros (7 strains), and other Peptostreptococcus species (3 strains).
Clostridium perfringens was always inhibited by all the agents tested at the breakpoint level except for clindamycin (81% at 4 ,ug/ml, 100% at 8 ,ug/ml). Non-sporeforming gram-positive rods were inhibited very well by all the drugs except, predictably, metronidazole. The gram-positive anaerobic cocci were completely inhibited by all the agents except clindamycin, which inhibited 77% at 2 ,ug/ml, 83% at 4 ,ug/ml, and 87% at 8 ,ug/ml. The effect of the inoculum on the MIC of each agent against 25 strains of the B. fragilis group was evaluated as follows. Organisms were grown in supplemented thioglycolate broth to the density of a no. 3 McFarland standard (approximately 109 CFU/ml). Samples of 1 ml were removed and serially diluted 10-fold, resulting in final counts of 104, 105, and 106 CFU. The remaining broth (at 109 CFU/ml) was concentrated (by centrifugation and resuspension in 0.1 volume) 10-fold, resulting in a final inoculum of 107 CFU. The values in Table 2 represent the geometric mean fold increase in MICs from the lowest inoculum (i.e., 104) to the highest (107) and are similar to those reported by Jacobus et al. (N. V. Jacobus, G. J. Cuchural, and F. P. Tally, Abstr. Annu. Meet. Am. Soc. Microbiol. 1987, A-34, p. 6). Only ceftizoxime showed a dramatic inoculum effect, although even the more subtle changes may affect the reported percentages resistant at the breakpoint, because of the phenomenon of clustering of MICs about certain concentrations (13) .
We noted that differences in techniques between various laboratories, coupled with both the clustering phenomenon described above and the differences in the proportions of various species tested, may lead to wide variations in 
